임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

28건 표시

2상모집 예정· Central Serous Chorioretinopathy (CSC)
만성 중심성 장액성 맥락막망막병증에서의 파리시맙: 무작위 대조 임상시험
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
협력: 로슈
상세 →NCT07681167
2상모집 예정· Relapsed /Refractory DLBCL
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
협력: 로슈
상세 →NCT07634289
단계 미표기모집 예정· Multiple Sclerosis
Cognitive Musical Screening and Therapeutic Innovation in Multiple Sclerosis
협력: 로슈
상세 →NCT07552428
2상모집 예정· Lymphocytic Leukemia
Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
협력: 로슈
상세 →NCT07566364
2상모집 예정· Obesity or Overweight
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
리드: 로슈
상세 →NCT07589686
1상모집 예정· Intracerebral Hemorrhage
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
협력: 로슈
상세 →NCT06696131
3상모집 예정· Non-small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
상세 →NCT07541170
2상모집 예정· Advanced Lung Non-Small Cell Carcinoma
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
협력: 로슈
상세 →NCT07322341
4상모집 예정· Multiple Sclerosis
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
리드: 로슈
상세 →NCT07609719
2상모집 예정· Acute Myeloid Leukemia
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
협력: 로슈
상세 →NCT06903702
2상모집 예정· Relapsing-remitting Multiple Sclerosis
A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
리드: 로슈
상세 →NCT07503340
1상모집 예정· Metastatic Colorectal Cancer
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
리드: 로슈
상세 →NCT07416552
1상모집 예정· Lupus Erythematosus, Systemic
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
리드: 로슈
상세 →NCT07629583
단계 미표기모집 예정· Spinal Muscle Atrophy
A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA)
리드: 로슈
상세 →NCT07531719
3상모집 예정· Early Breast Cancer
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
리드: 로슈
상세 →NCT07541079
1상모집 예정· Systemic Lupus Erythematosus
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
리드: 로슈
상세 →NCT06984341
2상모집 예정· Waldenstrom Macroglobulinemia
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
협력: 일라이 릴리, 로슈
상세 →NCT07548450
2상모집 예정· Breast Cancer
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.
협력: 노바티스, 로슈
상세 →NCT07618390
2상모집 예정· Diffuse Large B Cell Lymphoma
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
협력: 로슈
상세 →NCT07502872
3상모집 예정· Hepatocellular Carcinoma (HCC)
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
협력: 로슈
상세 →NCT06680258
2상모집 예정· Follicular Lymphoma
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
협력: 로슈
상세 →NCT07191249
해당없음모집 예정· Multiple Sclerosis
Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis
협력: 로슈
상세 →NCT07181811
단계 미표기모집 예정· Food Allergy Proved
Food Allergy Registry and Awareness Campaign in Puerto Rico
협력: 로슈
상세 →NCT07039266
1상모집 예정· Acute Ischemic Stroke
Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
협력: 로슈
상세 →NCT06801054
해당없음모집 예정· Parkinson Disease
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
협력: 로슈
상세 →NCT06993142
2상모집 예정· Diffuse Large B-Cell Lymphoma
Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL
협력: 로슈
상세 →NCT07012980
해당없음모집 예정· Heart Failure
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
협력: 로슈
상세 →NCT06667128
2상모집 예정· Lung Cancer
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
협력: 로슈
상세 →NCT05859217

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.